- Home
- UBFO vs NVCT Comparison
UBFO vs NVCT Comparison
Compare UBFO & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBFO
- NVCT
- Stock Information
- Founded
- UBFO 1987
- NVCT 2020
- Country
- UBFO United States
- NVCT United States
- Employees
- UBFO N/A
- NVCT N/A
- Industry
- UBFO Major Banks
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- UBFO Finance
- NVCT Health Care
- Exchange
- UBFO Nasdaq
- NVCT Nasdaq
- Market Cap
- UBFO 162.0M
- NVCT 184.9M
- IPO Year
- UBFO N/A
- NVCT 2022
- Fundamental
- Price
- UBFO $8.35
- NVCT $8.13
- Analyst Decision
- UBFO
- NVCT Strong Buy
- Analyst Count
- UBFO 0
- NVCT 3
- Target Price
- UBFO N/A
- NVCT $17.00
- AVG Volume (30 Days)
- UBFO 22.1K
- NVCT 97.5K
- Earning Date
- UBFO 07-17-2025
- NVCT 08-05-2025
- Dividend Yield
- UBFO 5.70%
- NVCT N/A
- EPS Growth
- UBFO N/A
- NVCT N/A
- EPS
- UBFO 0.77
- NVCT N/A
- Revenue
- UBFO $47,362,000.00
- NVCT N/A
- Revenue This Year
- UBFO N/A
- NVCT N/A
- Revenue Next Year
- UBFO N/A
- NVCT N/A
- P/E Ratio
- UBFO $10.80
- NVCT N/A
- Revenue Growth
- UBFO N/A
- NVCT N/A
- 52 Week Low
- UBFO $7.07
- NVCT $4.44
- 52 Week High
- UBFO $10.49
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- UBFO 44.46
- NVCT 37.24
- Support Level
- UBFO $8.04
- NVCT $8.79
- Resistance Level
- UBFO $8.74
- NVCT $9.30
- Average True Range (ATR)
- UBFO 0.23
- NVCT 0.50
- MACD
- UBFO -0.02
- NVCT -0.11
- Stochastic Oscillator
- UBFO 44.29
- NVCT 12.43
About UBFO United Security Bancshares
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.